Previous Article | Next Article ![]()
Infect. Immun., 05 1997, 1849-1855, Vol 65, No. 5
MX Zhang and B Klein
Complement plays a key role in phagocyte recognition and killing of
Blastomyces dermatitidis, but little is known about how complement
components interact with the yeast. We report the characteristics of
activation, binding, and processing of C3 by B. dermatitidis. In pooled
normal human serum (NHS), deposition of C3 on the yeast was detectable
within 2 min, whereas in NHS containing MgEGTA, deposition was delayed by 6
min, indicating that the yeast activates C3 by both classical and
alternative pathways. When both pathways were operative, maximal binding of
4.5 x 10(6) C3 molecules/cell was achieved in less than 30 min. In the
absence of the classical pathway, yeast cells bound 80% of the maximum C3,
indicating that the yeast intrinsically activates the alternative pathway.
Delayed deposition of C3 in NHS-MgEGTA was similar to that in NHS
preabsorbed by the yeast or by immobilized protein A/G to remove serum
immunoglobulin. Purified immunoglobulin restored C3 binding to NHS
preabsorbed by the yeast, suggesting that antibody in nonimmune serum
initiates the classical pathway. beta-Glucan absorption of NHS abolished
the classical pathway, suggesting that cell wall beta- glucan is a target
of initiating antibodies. Hydroxylamine treatment of NHS-opsonized yeast
cells showed that 76% of C3 was bound to yeast cells by ester linkage,
supporting a role for hydroxyl groups on cell wall polysaccharides.
Hydroxylamine-cleaved fragments were chiefly C3b and iC3b; 70% of
hydroxylamine-sensitive C3b was converted to iC3b within 1 min of
opsonization, and the ratio was stable over 1 h. Our data predict that C3b
and iC3b on opsonized yeast cells direct binding to CR1 and CR3 receptors
on human phagocytes, which, in turn, may influence the fate of this
host-pathogen interaction.
Copyright © 1997, American Society for Microbiology
Activation, binding, and processing of complement component 3 (C3) by Blastomyces dermatitidis
Department of Pediatrics, Comprehensive Cancer Center, University of Wisconsin Medical School, University of Wisconsin Hospital and Clinics, Madison 53792, USA.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|